You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 14, 2025

Drug Price Trends for PHENTERMINE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for PHENTERMINE

Average Pharmacy Cost for PHENTERMINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
PHENTERMINE 15 MG CAPSULE 11534-0157-03 0.08886 EACH 2025-01-22
PHENTERMINE 15 MG CAPSULE 11534-0157-01 0.08886 EACH 2025-01-22
PHENTERMINE 15 MG CAPSULE 10702-0026-10 0.08886 EACH 2025-01-22
PHENTERMINE 15 MG CAPSULE 10702-0026-01 0.08886 EACH 2025-01-22
PHENTERMINE 37.5 MG TABLET 68094-0702-70 0.06099 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for PHENTERMINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
PHENTERMINE HCL 37.5MG TAB Bryant Ranch PrePack DBA Bryant Ranch PrePack 72162-1628-03 30 2.71 0.09033 EACH 2024-03-08 - 2025-04-30 FSS
PHENTERMINE HCL 37.5MG CAP Bryant Ranch PrePack DBA Bryant Ranch PrePack 72162-1562-00 1000 99.50 0.09950 EACH 2024-03-08 - 2025-04-30 FSS
PHENTERMINE HCL 30MG CAP Bryant Ranch PrePack DBA Bryant Ranch PrePack 72162-1564-01 100 18.59 0.18590 EACH 2024-03-08 - 2025-04-30 FSS
PHENTERMINE HCL 15MG CAP Bryant Ranch PrePack DBA Bryant Ranch PrePack 72162-1565-01 100 25.13 0.25130 EACH 2024-03-08 - 2025-04-30 FSS
PHENTERMINE HCL 37.5MG TAB Bryant Ranch PrePack DBA Bryant Ranch PrePack 72162-1628-00 1000 90.59 0.09059 EACH 2024-03-08 - 2025-04-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Phentermine

Introduction to Phentermine

Phentermine is a widely prescribed anti-obesity medication, particularly in the United States. It has been a staple in weight management treatments for decades, often used in combination with other drugs or as a standalone therapy.

Market Size and Growth

The global phentermine hydrochloride market is significant and growing. Here are some key statistics:

  • Current Market Size: The global phentermine hydrochloride market was valued at USD 370.26 million in 2024[3].
  • Projected Growth: This market is expected to grow to USD 567.86 million by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 6.30%[3].

Driving Factors

Several factors are driving the growth of the phentermine hydrochloride market:

  • Increasing Obesity: The rising prevalence of obesity globally is a major driver, as more individuals seek effective weight management solutions[3].
  • E-Commerce and D2C Channels: The expansion of e-commerce and direct-to-consumer (D2C) channels has made phentermine more accessible to a broader audience[3].
  • Regulatory and Healthcare Trends: Supportive government policies and increasing healthcare spending also contribute to the market's growth[1].

Market Segments

The phentermine hydrochloride market can be segmented in several ways:

  • By Type: The market is classified into capsules and tablets, with each form having its own market share and growth prospects[3].
  • By Application: Phentermine is used in various settings, including hospitals, clinics, and other healthcare facilities[3].

Pricing and Affordability

The cost of phentermine and other anti-obesity medications is a critical factor in their adoption:

  • Current Prices: Phentermine is generally more affordable compared to newer anti-obesity medications. For instance, the estimated minimum prices (EMPs) for anti-obesity medications, including phentermine combinations, are significantly lower than their national prices. However, the actual market prices can be high, limiting accessibility for many patients[2].
  • Comparison with Other Medications: Phentermine is often compared to other anti-obesity drugs like semaglutide, liraglutide, and tirzepatide, which have higher price points. For example, a 30-day course of semaglutide can cost around $804, making phentermine a more cost-effective option for many patients[2].

Regulatory and Clinical Updates

Phentermine continues to be a subject of clinical studies and regulatory updates:

  • Clinical Trials: Recent studies have compared phentermine with other anti-obesity medications, such as QSYMIA. For example, a postmarketing study showed that QSYMIA treatment was associated with reductions in blood pressure compared to phentermine, highlighting the ongoing evaluation of these medications[4].
  • Regulatory Environment: The regulatory landscape, especially in regions like the UK and France, is evolving. For instance, the French National Agency for the Safety of Medicines (ANSM) has heightened surveillance on medications like Ozempic due to misuse for weight loss, emphasizing the need for strict regulation and proper use of anti-obesity drugs[1].

Regional Market Analysis

The demand for phentermine varies across different regions:

  • North America: This region dominates the anti-obesity medication market, including phentermine, due to the high prevalence of obesity and supportive government policies. Phentermine is the most widely prescribed anti-obesity medication in the US, with over 8 million prescriptions annually[1][4].
  • Europe: The market in Europe, particularly in the UK and France, is growing but faces challenges such as regulatory scrutiny and supply issues affecting certain medications[1].
  • Middle East and Africa (MEA): The MEA region is expected to grow due to the high prevalence of obesity and increasing healthcare spending. Changing dietary habits and a growing middle class are driving the demand for effective therapeutic measures[1].

Key Takeaways

  • Market Growth: The phentermine hydrochloride market is expected to grow significantly, driven by increasing obesity rates and expanding distribution channels.
  • Pricing: Phentermine remains a cost-effective option compared to newer anti-obesity medications, but its actual market price can be a barrier to accessibility.
  • Regulatory Environment: Strict regulation and proper use of anti-obesity medications are crucial, as highlighted by regulatory bodies in various regions.
  • Regional Variations: The demand for phentermine varies by region, with North America being the dominant market.

FAQs

1. What is the current market size of the phentermine hydrochloride market? The global phentermine hydrochloride market was valued at USD 370.26 million in 2024[3].

2. What is the projected growth rate of the phentermine hydrochloride market? The market is expected to exhibit a CAGR of 6.30% from 2024 to 2031[3].

3. What are the main driving factors for the phentermine hydrochloride market? The main drivers include increasing obesity rates, expansion of e-commerce and D2C channels, and supportive healthcare trends[3].

4. How does the pricing of phentermine compare to other anti-obesity medications? Phentermine is generally more affordable than newer anti-obesity medications like semaglutide and liraglutide, but its actual market price can still be a barrier to accessibility[2].

5. Which region dominates the phentermine hydrochloride market? North America, particularly the US, dominates the market due to the high prevalence of obesity and supportive government policies[1][4].

Sources

  1. Grand View Research - Anti-obesity Medication Market Size & Share Report, 2030
  2. Wiley Online Library - Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment
  3. Proficient Market Insights - Global Phentermine Hydrochloride Market Research Report 2024
  4. BioSpace - VIVUS Shares Significant Regulatory Update on QSYMIA®

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.